Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)
Clinical trial NCT05569954 · COMPLETED
Trial details
- NCT number
- NCT05569954
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2023-10-30
- Enrollment
- 1484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.